PRESS RELEASE published on 08/26/2025 at 07:30, 7 months ago Nicox Announces Shareholder Q&A Webpage Available Nicox introduces Q&A webpage for shareholders on nicox.com, addressing common queries about the company and its operations. Contact communications@nicox.com for investor queries Shareholders Ophthalmology Nicox Q&A Webpage Investor Questions
PRESS RELEASE published on 08/26/2025 at 07:30, 7 months ago Nicox annonce la mise en ligne d’une page « Questions-Réponses » sur son site internet Nicox annonce la mise en ligne d’une page "Questions-Réponses" sur son site internet, fournissant des réponses aux questions fréquentes des actionnaires sur Nicox et son activité Investisseurs Analyse Ophtalmologie Nicox Questions-Réponses
BRIEF published on 08/12/2025 at 15:58, 7 months 14 days ago Soleus Capital Crosses Threshold in NICOX Voting Rights Actions Threshold Crossing Nicox Soleus Capital
BRIEF published on 08/12/2025 at 15:58, 7 months 14 days ago Franchissement de Seuil par Soleus Capital dans NICOX Droits De Vote Franchissement De Seuil Actions Nicox Soleus Capital
PRESS RELEASE published on 08/12/2025 at 15:53, 7 months 14 days ago Franchissement de seuils Déclaration de franchissement de seuils par Soleus Capital Management LP concernant NICOX SA, avec 4,63% des droits de vote suite à une cession d'actions Droits De Vote Franchissement De Seuils Cession D'actions Nicox SA Soleus Capital Management LP
BRIEF published on 08/08/2025 at 07:35, 7 months 18 days ago Nicox Expands Equity Financing with Vester Finance Equity Financing Nicox Share Dilution Phase 3 Results Vester Finance
BRIEF published on 08/08/2025 at 07:35, 7 months 18 days ago Nicox étend son financement par actions avec Vester Finance Financement Par Actions Nicox Dilution Des Actions Résultats De La Phase 3 Vester Finance
PRESS RELEASE published on 08/08/2025 at 07:30, 7 months 18 days ago Nicox Extends Existing Flexible Equity Financing Nicox extends PACEO equity line with Vester Finance by adding 5 million shares. NCX 470 Denali Phase 3 results expected in mid-August to mid-September 2025 Equity Financing Nicox Phase 3 Results NCX 470 Denali Vester Finance
PRESS RELEASE published on 08/08/2025 at 07:30, 7 months 18 days ago Nicox étend sa ligne de financement flexible existante Nicox prolonge sa ligne de financement avec Vester Finance, ajoutant 5M d'actions. Résultats attendus de l'étude Denali sur NCX 470 en août-septembre 2025 Nicox NCX 470 Financement Flexible Vester Finance Étude Denali
BRIEF published on 06/30/2025 at 07:35, 8 months 26 days ago Nicox franchit une étape importante dans l'essai clinique de phase 3 du NCX 470 Essai De Phase 3 Nicox Hypertension Oculaire NCX 470 Glaucome
Published on 03/26/2026 at 23:00, 5 hours 38 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 6 hours 33 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 6 hours 38 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 6 hours 38 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 7 hours 38 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/27/2026 at 04:00, 38 minutes ago Tech-Driven Restoration: Saving the World's Critically Endangered White-headed Langur
Published on 03/26/2026 at 20:48, 7 hours 50 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 9 hours 18 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 9 hours 29 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 18:17, 10 hours 21 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 10 hours 21 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 10 hours 38 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 10 hours 38 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
